Isofuran: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{reflist|2}} | |||
Latest revision as of 18:42, 4 September 2012
|
WikiDoc Resources for Isofuran |
|
Articles |
|---|
|
Most recent articles on Isofuran |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Isofuran at Clinical Trials.gov Clinical Trials on Isofuran at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Isofuran
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Isofuran Risk calculators and risk factors for Isofuran
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Isofuran |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Isofurans are nonclassic eicosanoids formed nonenzymatically by free radical mediated peroxidation of arachidonic acid. The isofurans are similar to the isoprostanes and are formed under similar conditions, but contain a substituted tetrahydrofuran ring. The concentration of oxygen affects this process; at elevated oxygen concentrations, the formation of isofurans is favored whereas the formation of isoprostanes is disfavored.[1]
References
- ↑ Roberts, LJ 2nd and Fessel, JP (2004 Mar). "The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation". Chem Phys Lipids. 128 ((1-2)): 173-86. doi:10.1111/j.1750-3639.2005.tb00511.x. Retrieved 2007-01-05. Check date values in:
|year=(help) PMID: 15037162